Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Clinuvel Pharmaceuticals Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Clinuvel Pharmaceuticals Ltd - ADR market cap is $310.64M.
What is the 52-week high for Clinuvel Pharmaceuticals Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clinuvel Pharmaceuticals Ltd - ADR 52 week high is $8.92 as of August 31, 2026.
What is the 52-week low for Clinuvel Pharmaceuticals Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clinuvel Pharmaceuticals Ltd - ADR 52 week low is $5.98 as of August 31, 2026.
What is Clinuvel Pharmaceuticals Ltd - ADR stock price today?
Clinuvel Pharmaceuticals Ltd - ADR stock price today is $6.09.
What was Clinuvel Pharmaceuticals Ltd - ADR stock price yesterday?
Clinuvel Pharmaceuticals Ltd - ADR stock price yesterday was $6.16.
What is the PE ratio of Clinuvel Pharmaceuticals Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Clinuvel Pharmaceuticals Ltd - ADR's P/E ratio is 13.29.
What is the Price-to-Book ratio of Clinuvel Pharmaceuticals Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Clinuvel Pharmaceuticals Ltd - ADR P/B ratio is 1.6431.
What is the 50-day moving average of Clinuvel Pharmaceuticals Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Clinuvel Pharmaceuticals Ltd - ADR 50-day moving average is $7.07.